L
Louisa von Baumgarten
Researcher at Ludwig Maximilian University of Munich
Publications - 82
Citations - 2532
Louisa von Baumgarten is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 17, co-authored 45 publications receiving 2035 citations. Previous affiliations of Louisa von Baumgarten include Charité.
Papers
More filters
Journal ArticleDOI
Real-time imaging reveals the single steps of brain metastasis formation.
Yvonne Kienast,Louisa von Baumgarten,Martin Fuhrmann,Wolfgang E. F. Klinkert,Roland Goldbrunner,Jochen Herms,Frank Winkler +6 more
TL;DR: It was possible to track the fate of individual metastasizing cancer cells in vivo in relation to blood vessels deep in the mouse brain over minutes to months and provide new insights into their evolution and response to therapies.
Journal ArticleDOI
Imaging glioma cell invasion in vivo reveals mechanisms of dissemination and peritumoral angiogenesis.
Frank Winkler,Yvonne Kienast,Martin Fuhrmann,Louisa von Baumgarten,Steffen Burgold,Gerda Mitteregger,Hans A. Kretzschmar,Jochen Herms +7 more
TL;DR: Dynamic MPLSM for more than 48 h revealed that single invasive glioma cells induced intussusceptive microvascular growth and capillary loop formation, providing an explanation for their interdependence.
Journal ArticleDOI
A novel role of sphingosine 1-phosphate receptor S1pr1 in mouse thrombopoiesis
Lin Zhang,Lin Zhang,Martin Orban,Martin Orban,Michael Lorenz,Michael Lorenz,Verena Barocke,Verena Barocke,Daniela Braun,Daniela Braun,Nicole Urtz,Nicole Urtz,Christian Schulz,Christian Schulz,Marie-Luise von Brühl,Marie-Luise von Brühl,Anca Tirniceriu,Anca Tirniceriu,Florian Gaertner,Florian Gaertner,Richard L. Proia,Thomas Graf,Steffen-Sebastian Bolz,Eloi Montanez,Marco Prinz,Alexandra Müller,Louisa von Baumgarten,Andreas Billich,Michael Sixt,Reinhard Fässler,Ulrich H. von Andrian,Tobias Junt,Steffen Massberg +32 more
TL;DR: Sphingosine 1-phosphate guides the elongation of megakaryocytic proplatelet extensions and triggers their shedding.
Journal ArticleDOI
Bevacizumab has differential and dose-dependent effects on glioma blood vessels and tumor cells.
Louisa von Baumgarten,David Brucker,Anca Laura Tirniceru,Yvonne Kienast,Stefan Grau,Steffen Burgold,Jochen Herms,Frank Winkler +7 more
TL;DR: Regression of glioma cells can occur independently from vascular regression, suggesting that high doses of bevacizumab have indirect anticancer cell properties in vivo.
Journal ArticleDOI
High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial.
Gerald Illerhaus,Benjamin Kasenda,Gabriele Ihorst,Gerlinde Egerer,Monika Lamprecht,Ulrich Keller,Hans-Heinrich Wolf,Carsten Hirt,Stephan Stilgenbauer,Mascha Binder,Peter Hau,Matthias Edinger,Norbert Frickhofen,Martin Bentz,Robert Möhle,Alexander Röth,Michael Pfreundschuh,Louisa von Baumgarten,Martina Deckert,Claudia Hader,Heidi Fricker,Elke Valk,Elisabeth Schorb,Kristina Fritsch,Jürgen Finke +24 more
TL;DR: HCT-ASCT with thiotepa and carmustine is an effective treatment option in young patients with newly diagnosed primary CNS lymphoma, but further comparative studies are needed.